• Explore /
  • Poster
  • / Salvage radiotherapy (SRT) in combination with pembrolizumab in patients with PSA persistence or biochemical recurrence after radical prostatectomy due to prostate cancer.

Salvage radiotherapy (SRT) in combination with pembrolizumab in patients with PSA persistence or biochemical recurrence after radical prostatectomy due to prostate cancer.

Abstract Poster

Authors

null

Markus Grabbert

Dept. of Urology - University Hospital Freiburg, Freiburg, Germany

Markus Grabbert , Constantinos Zamboglou , Annika Josef , August Sigle , Simon K.B. Spohn , Anca L. Grosu , Christian Gratzke

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04931979

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr TPS212)

DOI

10.1200/JCO.2022.40.6_suppl.TPS212

Abstract #

TPS212

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Alan Dal Pra

First Author: Shun Zhang

First Author: Alberto Carretero-González

First Author: Yao Zhu